Full Explanation Reduces Seniors' Anxiety about Lung Cancer Screening

the ONA take:

A new study of participants in the National Lung Screening Trial (NLST) age 55 to 74 years found that fully informing patients about the meaning of screening results reduces anxiety. The consent form for the NLST was vetted by patients and clinicians and aimed to fully inform patients about the tests, in particular that the initial screening often shows abnormal findings. Low-dose CT screening is recommended for people age 55 to 80 years who are at high risk for lung cancer; however, concern that the high rate of false positive will cause undue worry and fear among people is a major barrier to adopting the screening. The investigators report the results are gratifying in that a significant concern can be mitigated. The results also reinforce the importance of communication between patients and health care providers for decision-making and understanding the implications of test results.

Full Explanation Reduces Seniors' Anxiety about Lung Cancer Screening
Full Explanation Reduces Seniors' Anxiety about Lung Cancer Screening
A new study of participants in the National Lung Screening Trial (NLST), the results of which are published today in Cancer, found evidence that men and women between the ages of 55 and 74 who had an abnormal finding on a lung cancer screening test did not experience more anxiety or reduced quality of life than did those who were screened and found to be cancer-free.
READ FULL ARTICLE From San Antonio Express-News
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs